Further delineation of the phenotype associated with heterozygous mutations in <i>ZFHX1B</i>
Meredith Wilson(Children's Hospital at Westmead), Michel Goossens(Inserm), Catherine Barrey(Hôpital Saint- Camille), Sharron Townshend(King Edward Memorial Hospital), David Mowat(UNSW Sydney), Harry Zehnwirth, Jill Clayton‐Smith(St Mary's Hospital), Michael Gattas(Boys Town), Stephen R. Braddock(University of Virginia Health System), Dian Donnai(Manchester University NHS Foundation Trust), Bronwyn Kerr(Manchester Academic Health Science Centre), Valère Cacheux(Inserm), Cynthia J. Curry(Baylor College of Medicine), Danny Cass(Children's Hospital at Westmead), Florence Dastot‐Le Moal(Inserm), Helena Kääriäinen(Finnish Institute for Health and Welfare), Salim Aftimos(Auckland City Hospital)
Cited by 105
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|863
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Angelman syndrome 2005: Updated consensus for diagnostic criteria
|American Journal of Medical Genetics Part A|2006|645
Disruption of Neurexin 1 Associated with Autism Spectrum Disorder
|The American Journal of Human Genetics|2008|581